Sewon Cellontech, a South Korean regenerative medicine company, has officially launched its CaHA-based collagen booster 'Facetem' in Thailand in partnership with BJC (Berli Jucker Public Company Limited), a leading Thai healthcare and retail conglomerate. The move targets Thailand's mature medical aesthetics market, offering overseas buyers a clinically differentiated collagen stimulator with growing regional demand for regenerative aesthetic solutions.
Partnership and market access
BJC, a 140-year-old Thai listed company, operates the Big C retail chain and has extensive healthcare and distribution networks. Sewon Cellontech will leverage BJC's medical aesthetics infrastructure to supply Facetem and conduct academic marketing activities across Thailand. This partnership provides a direct channel for importers and distributors seeking entry into Southeast Asia's aesthetic device and injectable supply chain.
Product positioning and global footprint
Facetem is the global brand name for Sewon Cellontech's CaHA product, marketed as 'DCLASSY CaHA' in South Korea and Indonesia. It is currently exported to over 32 countries and holds the second-largest global market share in the CaHA segment. The product is positioned as a regenerative biostimulator that induces collagen and elastin production, differentiating it from conventional dermal fillers.
Clinical training and symposium highlights
The launch included a two-day event. Day one featured a Train-the-Trainer hands-on session for Thai medical aesthetic doctors and Siriraj Medical School fellows, who evaluated Facetem's injection feel, handling, and tissue distribution. Attendees praised its smooth injection experience, predictable outcomes, and natural tissue response due to uniform particle structure.
Day two hosted the official symposium 'Facetem Beyond Dual – The Lattice Pore Structural Regeneration'. Key opinion leaders, including Prof. Dr. Rungsima from Thailand and Dr. Carmelo Crisafulli from Dubai, presented on CaHA's evolution as a regenerative biostimulator and expanded clinical applications for face, neck, and hands. Dr. Hong Ki-woong from Samskin Plastic Surgery introduced the 'CAST CODE' protocol, categorizing CaHA procedures into lifting, structural contouring, and skin regeneration.
Market context and buyer signals
Thailand is one of Southeast Asia's most mature medical aesthetics markets, with rising demand for regenerative treatments that combine volume correction with tissue regeneration and skin improvement. For overseas distributors and clinic buyers, Facetem's entry via BJC's established network signals a reliable supply route and growing academic support in the region.
What buyers should watch
Importers and clinic operators should monitor Sewon Cellontech's expansion of clinical data and training programs in Thailand, which may serve as a regional hub for Southeast Asian distribution. The product's dual positioning as a collagen booster and biostimulator aligns with current market trends toward non-surgical regenerative aesthetics, potentially offering a competitive alternative to existing CaHA products.
Source: Read the original report | Published: June 09, 2026